KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
59 hedge funds and large institutions have $36.3M invested in Kalaris Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 31 reducing their positions, and 14 closing their positions.
Holders
59
Holders Change
-12
Holders Change %
-16.9%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
31
Closed
14
Calls
$26K
Puts
–
Net Calls
+$26K
Net Calls Change
-$174K
Top Buyers
1 |
OCA
1
Octagon Capital Advisors
New York
|
$9.06M |
2 |
AI
2
Acuitas Investments
Seattle,
Washington
|
$865K |
3 |
3
Amundi
Paris,
France
|
$36K |
4 |
4
Osaic Holdings
Scottsdale,
Arizona
|
$15.1K |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$19.5K |